Moving from Compliance to Quality

Too narrow a focus on regulatory compliance may prevent organizations from embracing-and profiting from-quality and operational excellence.

Regulators and pharmaceutical manufacturers are debating the best way to measure quality. Discussions center on management and corporate cultures and how they impact operational excellence and customer-focused quality. Observers see the need for more proactive pharmaceutical company managers who actively support and invest in quality efforts and employee training.

Read this article in Pharmaceutical Technology’s December 2019 Regulatory Sourcebook.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook, December 2019
December 2019
Pages: 6–10

Citation

When referring to this article, please cite it as A. Shanley, “Moving from Compliance to Quality," Pharmaceutical Technology Regulatory Sourcebook eBook (December 2019).

Articles in this issue

almost 6 years ago

Article

Revision Process for Global/National Pharmacopoeias (eBook)

almost 6 years ago

Article

Regulatory and Standard Setting Organizations

almost 6 years ago

Article

Resources, Guidelines, and Guidance Documents

almost 6 years ago

Article

Design of Experiments Gains Ground in Biopharma Development

almost 6 years ago

Article

Warning Letters Signal Steps to Compliance

almost 6 years ago

Article

Quality Risk Management Plans Create Effective Quality Systems

almost 6 years ago

Article

Surveillance Process for Industry: Monitoring Pharmacopoeia Revisions (eBook)

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!